Perspective Therapeutics Total Risk Alpha
| CATX Stock | | | 4.60 -0.26 -5.35% |
Reference data associated with the Total Risk Alpha technical indicator for Perspective Therapeutics. Values may reflect normalized price or volume observations.
Perspective Therapeutics has current Total Risk Alpha of 2.42. The total risk alpha measures the performance of an asset by comparing its returns with those of a selected benchmark portfolio.
Total Risk Alpha | = | RFR + (ER[b] - ER[a]) | x | STD[a] / STD[b] |
| = | 2.42 | |
| ER[a] | = | Expected return on investing in Perspective Therapeutics |
| ER[b] | = | Expected return on market index or selected benchmark |
| STD[a] | = | Standard Deviation of returns on Perspective Therapeutics |
| STD[b] | = | Standard Deviation of selected market or benchmark |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
Total Risk Alpha Peers Comparison
Total Risk Alpha Relative To Other Indicators
Perspective Therapeutics ranks first in total risk alpha among leading competitors. It is currently under evaluation in maximum drawdown among leading competitors reporting about
31.94 of Maximum Drawdown per Total Risk Alpha. At
31.94 , Perspective Therapeutics's Maximum Drawdown-to-Total Risk Alpha multiple reflects the spread between these metrics
The benchmark portfolio represents the market risk matched to the total risk of the stock ETF or fund.
Compare Perspective Therapeutics to Peers
Other Technical Indicators